This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Eli Lilly and Co (LLY)

NYSE: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 4.68B 4.09B 4.35B 5.07B
Operating Gains/Losses 37.10M 0.00 0.00 -79.80M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -152.70M 361.80M -188.80M -319.10M
(Increase) Decrease in Inventories -286.50M -307.90M 203.10M 157.00M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 340.50M
(Decrease) Increase In Payables -70.30M -336.10M 591.40M -363.90M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 116.50M 231.00M 642.70M 0.00
Other Non-Cash Items -325.40M -320.80M 533.30M 164.70M
Net Cash From Continuing Operations 5.74B 5.30B 7.23B 6.86B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 5.74B 5.30B 7.23B 6.86B
Sale of Property, Plant & Equipment 179.40M 1.23B 25.30M 24.60M
Cash Used for Investing Activities
Sale of Short-Term Investments 3.32B 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.09B -1.04B -1.69B -1.19B
Acquisitions -43.70M -199.30M -307.80M -609.40M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -1.63B 439.50M -528.10M -905.80M
Cash Provided by Financing Activities
Net Cash From Investing Activities -2.07B -2.83B -4.82B -3.16B
Issuance of Debt 0.00 0.00 0.00 1.20M
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 0.00 0.00 0.00
Repayment of Long-Term Debt -10.50M -1.50B -54.60M -1.10M
Repurchase of Capital Stock -1.70B -721.10M 0.00 0.00
Payment of Cash Dividends -2.12B -2.19B -2.18B -2.17B
Other Financing Charges, Net 0.00 -10.50M -135.20M 143.30M
Net Cash From Financing Activities -3.83B -4.42B -2.37B -2.02B
Effect of Exchange Rate Changes -21.50M 43.90M -110.90M -144.80M
Net Change in Cash & Cash Equivalents -188.60M -1.90B -70.70M 1.53B
LLY News

LLY Eli Lilly and Co

Analysts Ratings for LLY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 5 5
Moderate Buy 0 0 0 0
Hold 8 8 8 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 2
GET LLY ANALYST REPORT

Brokerage Partners

LLY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs